Severe funding pressures on primary healthcare providers are making it harder for people to enrol at a general practice, many of which have closed their books to new patients, says the General Practice Owners Association (GenPro)
Pharmac – Te Pātaka Whaioranga is looking to increase access to five medicines for a number of cancers, including kidney and lung cancers, and other health conditions
Health minister Shane Reti says the latest capitation increase offer for general practices is the best the Government could do during tough times and GPs can increase their fees to cover costs
Years of advocacy from Bowel Cancer New Zealand (NZ) and other groups calling for new bowel cancer drugs has led to a funding announcement from Pharmac for two new medicines, cetuximab (Erbitux) and pembrolizumab (Keytruda)
Ensuring the health system has the necessary ‘digital and physical infrastructure’ requires more than just words, according to the Digital Health Association (DHA)
Associate Health Minister for Pharmac David Seymour says today’s announcement that Pharmac is opening consultation on new cancer medicines is great news for Kiwi cancer patients and their families
It’s a historic day for New Zealanders with the most aggressive form of breast cancer, as Pharmac announces a consultation that would see pembrolizumab (brand name Keytruda) funded for people with advanced triple negative breast cancer (TNBC) from 1 October
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management